[Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis].
D000818:Animals; D004195:Disease Models, Animal; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000378:metabolism; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000627:therapeutic use*; D010101:Oxygen Consumption; D011704:Pyelonephritis / Q000188:drug therapy*; D051381:Rats
D009268:Nalidixic Acid
Studien zur Nalidixinsäure-Empfindlichkeit eines E. coli-Stammes bei der experimentellen Pyelonephritis.